02708nas a2200205 4500008004100000245014100041210006900182260001900251300001000270490000600280520201500286653002202301653003402323653002202357653002002379653001702399100002402416700002102440856004102461 2014 eng d00aComparison of Safety, Efficacy and Cost Effectiveness of Intravaginal Misoprostol and Intracervical Dinoprostone for Induction of Labour0 aComparison of Safety Efficacy and Cost Effectiveness of Intravag cSeptember 2014 a68-720 v33 a

Background: Misoprostol is more efficacious than dinoprostone for induction of labour. But the adverse effects pro-duced by misoprostol were different. The aims of this study was to compare the safety, efficacy, cost effectiveness of intravaginal misoprostol and intracervical dinoprostone for induction of labour and their effects on intrapartum complications, mode of delivery and neonatal outcome. Materials and Methods: This is a randomized, parallel, two tailed, prospective, open label comparative trial. Sixty pregnant women were included in the study and it was carried out in the Department of Obstetrics, Government General Hospital, Kurnool Medical College, Kurnool during the period Dec. 2009 - June 2010. Out of 60 patients, 30 received miso-prostol 25 mcg intravaginally and 30 received dinoprostone 0.5 mg intracervically. Analysis and comparison of various parameters like induction- delivery interval, mode of delivery, neonatal outcome, foeto-maternal complications and cost of the drug were done. Mean and standard deviation of all observations were calculated and tabulated with the help of ‘Microsoft Excel’. Comparison was done by applying student’s t -test. Statistical significance was assigned at P<0.05. Results: Misoprostol is more efficacious for cervical ripening and labor induction than dinoprostone. Misoprostol group had more number of vaginal deliveries, lesser requirement of oxytocin for labor augmentation, more number of vaginal deliveries within 12 hrs, less induction failures and was cost effective. However, it was reported to have slightly higher incidence of uterine contractility abnormalities and foetal complications. Conclusion: Misoprostol is more efficacious than dinoprostone. However uterine contraction abnormalities, fetal com-plications should be carefully assessed by close monitoring of labor by intrapartum cardiotocography and partogram.

10aCervical ripening10aInduction - delivery interval10aInduction failure10aLabor induction10aTachysystole1 aKumari, Dara, Aruna1 aRadhika, Gujjala uhttps://ijphs.org/article/2014/3/3-3